1.
Effective Asthma Management: Is It Time to Let the AIR out of SABA?
2.
3.
4.
5.
Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice
Context, Culture, and the Complexity of De-Implementing Low-Value Care; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and th...
Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design
Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It
Reducing Low-Value Care: Uncertainty as Crucial Cross-Cutting Theme; Comment on “Key Factors That Promote Low-Value Care: Views of Experts From the United States, Canada, and the N...
Beyond Microsystem Fixes: Targeting National Drivers of Low-Value Care; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and th...
Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice
Overview of the Drivers of Low-Value Care; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands”
SABA Overuse in Russia – Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study
6.
7.
8.